Rep. Debbie Wasserman Schultz

Maddy summaryHR 1715, the Public Health Funding Restoration Act, restores annual funding for the Prevention and Public Health Fund to $2 billion starting in fiscal year 2026. This bill directly affects federal public health programs, including the CDC’s immunization initiatives and state/local health departments, by reversing prior funding cuts. It amends the Affordable Care Act to set the annual funding level at $2 billion, enabling continued support for evidence-based prevention programs like childhood lead poisoning prevention, tobacco cessation, and immunizations. The restored funding aims to maintain existing programs proven to reduce healthcare costs and improve community health outcomes. This change specifically targets the Prevention and Public Health Fund (Section 4002 of the ACA) without creating new programs.

Maddy summaryThe Keep Americans Safe Act (HR 1674) restricts the sale, transfer, and possession of large capacity ammunition feeding devices (LCFDs) - defined as magazines or similar devices holding more than 15 rounds of ammunition - for most individuals. Exceptions allow law enforcement officers (including campus law enforcement), retired officers, and nuclear security personnel to possess LCFDs under specific conditions. The bill requires new LCFDs to have serial numbers and manufacturing dates, permits federal seizure of violative devices, and authorizes federal grant programs to fund buy-back initiatives for LCFDs. It directly affects gun owners and manufacturers while preserving access for covered law enforcement and security personnel.

Maddy summaryHR 1657, the Humane Cosmetics Act of 2025, prohibits cosmetic companies from conducting or contracting animal testing for products sold in the U.S. beginning one year after the law takes effect. It also bans the sale or transport of cosmetics developed using such testing after that date, with limited exemptions (e.g., for foreign regulatory requirements or when no non-animal safety alternatives exist). The bill directly affects cosmetic manufacturers, retailers, and distributors by requiring them to shift to non-animal testing methods. The Food and Drug Administration (FDA) will enforce the law, including reviewing records and imposing civil penalties for violations.

Maddy summaryThe PAST Act of 2025 amends the Horse Protection Act to ban harmful practices known as "soring," which deliberately cause pain to horses to exaggerate their gait for shows. It specifically prohibits devices like action devices (e.g., boots causing friction) and weighted shoes on Tennessee Walking Horses, Racking Horses, and Spotted Saddle Horses at events. The bill increases penalties, including escalating disqualifications for repeat offenses (180 days → 1 year → 3 years) and raises fines for violations to $5,000 per offense. It also requires stricter licensing for inspectors and mandates public posting of violation records to help event organizers enforce rules.

Maddy summaryThe American Dream and Promise Act of 2025 would create pathways to permanent residency for certain immigrant youth who entered the U.S. as children (Dream Act component) and for individuals from countries with Temporary Protected Status or Deferred Enforced Departure (American Promise Act component). To qualify, applicants must meet continuous physical presence requirements (since January 1, 2021 for Dream Act applicants, and for 3+ years for American Promise applicants), pass background checks, and satisfy educational or employment criteria. Conditional permanent resident status would be granted initially, with the option to convert to full permanent residency after meeting additional requirements like earning a degree, serving in the military for two years, or demonstrating three years of earned income. The bill includes fee exemptions for low-income applicants, establishes a grant program to assist applicants with legal help, and creates specific procedures for background checks and appeals.

Maddy summaryHRES 166 is a non-binding House resolution expressing U.S. support for the Iranian people's desire for a democratic, secular, and nonnuclear republic. It condemns the Iranian regime's terrorism, regional proxy wars, internal suppression of ethnic and religious minorities, and human rights abuses - including executions and repression of women-led protests. The resolution calls for holding the regime accountable through sanctions, supports the Ten-Point Plan for Iran’s democratic transition, and urges protection for Iranian political refugees in Albania. It does not create new laws but affirms U.S. policy alignment with Iranian protesters' demands.

Maddy summaryThis bill expands Medicare, Medicaid, and CHIP coverage for specific cancer diagnostic tests, directly affecting cancer patients enrolled in these programs. It requires Medicare to cover genetic tests like DNA sequencing (80% of cost) and limits testing frequency to once at diagnosis, once for recurrence, and as needed for treatment planning. Medicaid and CHIP must include these tests as mandatory coverage starting January 1, 2027, with states given flexibility to comply via state legislation. The bill also mandates a new HHS education program to inform doctors and the public about genomic testing for cancer care.

Maddy summaryThis bill extends duty-free access for Haitian apparel exports to the U.S. until September 30, 2035, under the Caribbean Basin Economic Recovery Act. It increases the minimum percentage of eligible apparel that qualifies for duty-free treatment to 60% or more and adjusts import limits to 1.25% of the U.S. apparel import market. The bill also restores eligibility for specific apparel items that lost duty-free status due to past tariff schedule changes. These changes directly benefit Haitian apparel manufacturers and U.S. importers of Haitian-made clothing by maintaining market access.

Maddy summaryThis bill changes rules for prescribing certain medications used to treat substance use disorders. It allows healthcare providers to use telehealth for the initial patient evaluation instead of requiring an in-person visit, but only for drugs approved by the FDA for addiction treatment (schedules III-V). The telehealth must meet specific standards, including real-time audio/video communication. This affects doctors and other practitioners who prescribe these medications for substance use disorders.

Maddy summaryThis bill amends Medicare rules to allow nurse practitioners and physician assistants to certify diabetic shoe coverage for Medicare beneficiaries with diabetes, expanding the current requirement that only physicians could provide this documentation. It directly affects Medicare patients needing specialized footwear due to diabetes and healthcare providers like NPs and PAs who would now be authorized to meet the certification requirement. The key change modifies Section 1861(s)(12) of the Social Security Act to insert "nurse practitioner, or physician assistant" in all relevant sections of the documentation rules. This update simplifies access to covered diabetic shoes by broadening which healthcare professionals can issue the necessary certification.